Skip to Main Content

2,837

Views

1

CrossRef citations to date

0

Altmetric

Reports

An efficient system for bioconjugation based on a widely applicable engineered O-glycosylation tag

Short title: Controlled bioconjugation via O-glycan engineering

Thomas V. Murraya Biologics Engineering, R&D, AstraZeneca, Cambridge, UKCorrespondence[email protected]
View further author information

,

Kasia Kozakowska-McDonnellb Biopharmaceutical Development, R&D, AstraZeneca, Cambridge, UKView further author information

,

Adam Tibblesa Biologics Engineering, R&D, AstraZeneca, Cambridge, UKView further author information

,

Annabel Taylorb Biopharmaceutical Development, R&D, AstraZeneca, Cambridge, UKView further author information

,

Daniel Higazib Biopharmaceutical Development, R&D, AstraZeneca, Cambridge, UKView further author information

,

Emmanuel Rossyb Biopharmaceutical Development, R&D, AstraZeneca, Cambridge, UKView further author information

,

Alessandra Rossic Cardiovascular Renal and Metabolism, R&D, AstraZeneca, Cambridge, UKView further author information

,

Sivaneswary Genapathye Discovery Sciences, R&D, AstraZeneca, Cambridge, UKView further author information

,

Giulia Tamburrinoa Biologics Engineering, R&D, AstraZeneca, Cambridge, UKView further author information

,

Nicola Rathd Oncology R&D, AstraZeneca, Cambridge, UKView further author information

,

Natalie Tiguee Discovery Sciences, R&D, AstraZeneca, Cambridge, UKView further author information

,

Vivian Lindob Biopharmaceutical Development, R&D, AstraZeneca, Cambridge, UKView further author information

,

Tristan Vaughana Biologics Engineering, R&D, AstraZeneca, Cambridge, UKView further author information

&

Monika A. Papwortha Biologics Engineering, R&D, AstraZeneca, Cambridge, UKView further author information